Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.910
-0.200 (-4.87%)
Aug 26, 2026, 3:24 PM EDT - Market open
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $325.3 million as of August 26, 2026. Its market cap has increased by 348.66% in one year.
Market Cap
325.30M
Enterprise Value
272.69M
1-Year Change
348.66%
Ranking
Category
Stock Price
$3.91
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $325.30M, an increase of 1,429.90%. That is a compound annual growth rate of 59.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 325.30M | 134.67% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 362.53M |
| Palisade Bio | 360.74M |
| Sutro Biopharma | 355.50M |
| Abeona Therapeutics | 355.11M |
| SAB Biotherapeutics | 346.66M |
| Immuneering | 338.37M |
| ProQR Therapeutics | 335.87M |
| Anavex Life Sciences | 329.91M |